Mandate

Vinge has advised Elektroskandia in connection with the restructuring and divestment of Cylinda

October 21, 2024

Vinge has advised Elektroskandia AB (a Sonepar company) in connection with the restructuring and divestment of the Cylinda business to Vestel (through its subsidiary Vestel Holland B.V.).

Cylinda operates in the white goods sector, is headquartered in Rotebro and has approximately 100 employees.

Vinge’s team consisted of Matthias Pannier, Mathilda Persson, Desirée Hagenfeldt, Filip Magnusson, Victor Ericsson, Sebastian Örndahl and Alva Chambert.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025